Swissmedic Notice on Legacy Products
The article outlines the approach to be applied with respect to legacy medical devices in the context of transitional provisions.
The article outlines the approach to be applied with respect to legacy medical devices in the context of transitional provisions.
The article highlights the key points related to the regulatory requirements for combination studies intended to be carried out in Switzerland.
The new article provides further clarifications regarding the authorisation procedure to be followed by the parties interested in conducting combination studies in Switzerland.
The new article clarifies the approach to be followed when introducing modifications to combination studies already approved by Swissmedic.
The new article outlines the reporting requirements to be followed by the parties responsible for clinical investigations conducted in Switzerland.
The article outlines the key points related to Swissdamed, the country’s new information system for healthcare products.
RegDesk is recognized as a Regulatory Intelligence Representative Vendor! Learn more by reading the 2024 Gartner® Market Guide for Regulatory Intelligence Solutions.
Get the report